Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Re-setting the biologic rationale for thermal therapy.

Mark W Dewhirst1, Zeljko Vujaskovic, Ellen Jones

  • 1Department of Radiation Oncology, Duke University Medical Center, Durham, NC 27710, USA. dewhirst@radonc.duke.edu.

International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group
|December 13, 2005
PubMed
Summary

Early hyperthermia research overemphasized cell killing, leading to suboptimal cancer treatment protocols. Modern approaches focus on milder temperatures (39-42°C) to enhance radiotherapy and chemotherapy by modulating tumor biology.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Investigating initial patterns of progression on first-line treatment in patients with de novo metastatic breast cancer.

Breast cancer research and treatment·2026
Same author

Pharmacy faculty and students perceptions of artificial intelligence: A National Survey.

Currents in pharmacy teaching & learning·2025
Same author

A translational review of hyperthermia biology.

International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group·2025
Same author

Pharmacists' perceptions of artificial intelligence: A national survey.

Journal of the American Pharmacists Association : JAPhA·2024
Same author

Quality of Life Outcomes in Breast Cancer Patients Receiving Chemotherapy With or Without Radiation Therapy.

Clinical breast cancer·2024
Same author

Ultrafast dynamics of fluorene initiated by highly intense laser fields.

Physical chemistry chemical physics : PCCP·2024

Area of Science:

  • Oncology
  • Biophysics
  • Medical Engineering

Background:

  • Historical hyperthermia research (late 1970s-1980s) focused excessively on achieving direct cell killing as the primary measure of success.
  • This focus led to suboptimal clinical strategies, including inappropriate fractionation schedules, sequencing with radiotherapy, and unrealistic equipment performance goals.

Purpose of the Study:

  • To re-evaluate the biological effects of hyperthermia, particularly at sub-lethal temperatures (39-42°C).
  • To highlight how these milder hyperthermia effects can be leveraged to improve cancer treatment outcomes when combined with radiation and chemotherapy.

Main Methods:

  • Retrospective review of historical hyperthermia research and clinical application.
  • Analysis of current biological data on hyperthermia's effects in the 39-42°C range.

Related Experiment Videos

Main Results:

  • Hyperthermia at 39-42°C offers significant biological benefits, including inhibiting DNA repair, altering tumor perfusion and re-oxygenation, and enhancing drug/nanoparticle delivery.
  • These effects also include inducing heat shock responses and stimulating anti-tumor immunity, thereby improving tumor response to therapies.
  • Achievable and tolerable thermal goals are now possible, moving beyond the necessity of direct cell killing.

Conclusions:

  • The field of clinical hyperthermia needs to shift focus from solely cell killing to exploiting the broader biological effects of milder heat treatments.
  • Advancements in non-invasive thermometry and sophisticated delivery systems are crucial for optimizing these new therapeutic strategies.
  • An integrated approach combining biological understanding, engineering innovation, and clinical application is essential for advancing hyperthermia's role in cancer therapy.